<?xml version="1.0" encoding="UTF-8"?>
<SAMPLE_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <SAMPLE alias="SAMEA112286337" accession="ERS14397179">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397179</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286337</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286337</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251184</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC39</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-28</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Noord-Brabant</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/NB-EMC-5308/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC39</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286338" accession="ERS14397180">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397180</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286338</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286338</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251185</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC40</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Noord-Brabant</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/NB-EMC-5309/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC40</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286339" accession="ERS14397181">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397181</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286339</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286339</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251186</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC50</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-30</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Noord-Brabant</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/NB-EMC-5310/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC50</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286340" accession="ERS14397182">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397182</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286340</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286340</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251187</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC52</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-30</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Noord-Brabant</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/NB-EMC-5311/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC52</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286341" accession="ERS14397183">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397183</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286341</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286341</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251188</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC58</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-01</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Noord-Brabant</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/NB-EMC-5312/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC58</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286342" accession="ERS14397184">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397184</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286342</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286342</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251189</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC58</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Noord-Brabant</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/NB-EMC-5313/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC58</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286343" accession="ERS14397185">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397185</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286343</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286343</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251190</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC42</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zeeland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZE-EMC-4466/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC42</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286344" accession="ERS14397186">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397186</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286344</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286344</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251191</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC41</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zeeland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZE-EMC-4467/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC41</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286345" accession="ERS14397187">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397187</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286345</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286345</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251192</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC42</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-24</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zeeland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZE-EMC-4468/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC42</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286346" accession="ERS14397188">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397188</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286346</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286346</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251193</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC55</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zeeland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZE-EMC-4469/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC55</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286347" accession="ERS14397189">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397189</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286347</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286347</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251194</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC85</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-09</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zeeland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZE-EMC-4470/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC85</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286348" accession="ERS14397190">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397190</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286348</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286348</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251195</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC03</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-30</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7387/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC03</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286349" accession="ERS14397191">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397191</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286349</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286349</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251196</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC05</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-30</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7388/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC05</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286350" accession="ERS14397192">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397192</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286350</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286350</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251197</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC07</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7389/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC07</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286351" accession="ERS14397193">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397193</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286351</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286351</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251198</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC08</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-28</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7390/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC08</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286352" accession="ERS14397194">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397194</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286352</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286352</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251199</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC12</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-25</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7391/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC12</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286353" accession="ERS14397195">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397195</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286353</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286353</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251200</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC14</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7392/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC14</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286354" accession="ERS14397196">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397196</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286354</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286354</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251201</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC15</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7393/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC15</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286355" accession="ERS14397197">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397197</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286355</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286355</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251202</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC16</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7394/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC16</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286356" accession="ERS14397198">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397198</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286356</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286356</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251203</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC17</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7395/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC17</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286357" accession="ERS14397199">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397199</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286357</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286357</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251204</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC18</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7396/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC18</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286358" accession="ERS14397200">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397200</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286358</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286358</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251205</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7397/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC19</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286359" accession="ERS14397201">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397201</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286359</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286359</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251206</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC20</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-22</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7398/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC20</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286360" accession="ERS14397202">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397202</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286360</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286360</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251207</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC21</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-28</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7399/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC21</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286361" accession="ERS14397203">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397203</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286361</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286361</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251208</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC22</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-27</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7400/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC22</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286362" accession="ERS14397204">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397204</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286362</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286362</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251209</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-28</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7401/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC23</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286363" accession="ERS14397205">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397205</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286363</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286363</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251210</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC25</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-28</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7402/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC25</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286364" accession="ERS14397206">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397206</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286364</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286364</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251211</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7403/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286365" accession="ERS14397207">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397207</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286365</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286365</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251212</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC27</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7404/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC27</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286366" accession="ERS14397208">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397208</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286366</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286366</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251213</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC28</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7405/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC28</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286367" accession="ERS14397209">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397209</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286367</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286367</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251214</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-30</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7406/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286368" accession="ERS14397210">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397210</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286368</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286368</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251215</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC30</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-01</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7407/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC30</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286369" accession="ERS14397211">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397211</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286369</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286369</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251216</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC33</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-09</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7408/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC33</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286370" accession="ERS14397212">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397212</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286370</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286370</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251217</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC35</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-28</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7409/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC35</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286371" accession="ERS14397213">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397213</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286371</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286371</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251218</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC36</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-28</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7410/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC36</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286372" accession="ERS14397214">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397214</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286372</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286372</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251219</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC37</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-28</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7411/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC37</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286373" accession="ERS14397215">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397215</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286373</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286373</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251220</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC38</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-28</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7412/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC38</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286374" accession="ERS14397216">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397216</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286374</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286374</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251221</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC41</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7413/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC41</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286375" accession="ERS14397217">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397217</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286375</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286375</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251222</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC43</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7414/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC43</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286376" accession="ERS14397218">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397218</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286376</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286376</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251223</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC44</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7415/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC44</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286377" accession="ERS14397219">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397219</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286377</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286377</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251224</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC47</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-30</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7416/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC47</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286378" accession="ERS14397220">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397220</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286378</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286378</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251225</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC49</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-30</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7417/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC49</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286379" accession="ERS14397221">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397221</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286379</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286379</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251226</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC55</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-11-30</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7418/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC55</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286380" accession="ERS14397222">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397222</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286380</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286380</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251227</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC56</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-01</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7419/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC56</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286381" accession="ERS14397223">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397223</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286381</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286381</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251228</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC57</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-01</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7420/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC57</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286382" accession="ERS14397224">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397224</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286382</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286382</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251229</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC59</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-01</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7421/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC59</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286383" accession="ERS14397225">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397225</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286383</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286383</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251230</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC62</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-02</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7422/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC62</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286384" accession="ERS14397226">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397226</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286384</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286384</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251231</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC63</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-01</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7423/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC63</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286385" accession="ERS14397227">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397227</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286385</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286385</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251232</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC65</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-02</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7424/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC65</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286386" accession="ERS14397228">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397228</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286386</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286386</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251233</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC66</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-02</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7425/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC66</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286387" accession="ERS14397229">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397229</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286387</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286387</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251234</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC67</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-03</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7426/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC67</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286388" accession="ERS14397230">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397230</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286388</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286388</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251235</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC68</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-03</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7427/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC68</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286389" accession="ERS14397231">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397231</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286389</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286389</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251236</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC69</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-03</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7428/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC69</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286390" accession="ERS14397232">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397232</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286390</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-03-15</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286390</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251237</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-03-15T13:25:01Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC70</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7429/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC70</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286391" accession="ERS14397233">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397233</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286391</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-03-15</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286391</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251238</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-03-15T13:24:47Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC71</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7430/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC71</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286392" accession="ERS14397234">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397234</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286392</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-03-15</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286392</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251239</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-03-15T13:24:33Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run788_BC72</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7431/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run788_BC72</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286393" accession="ERS14397235">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397235</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286393</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286393</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251240</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC01</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-05</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7432/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC01</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286394" accession="ERS14397236">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397236</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286394</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286394</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251241</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC02</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-05</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7433/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC02</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286395" accession="ERS14397237">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397237</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286395</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286395</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251242</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC08</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-05</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7434/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC08</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286396" accession="ERS14397238">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397238</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286396</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286396</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251243</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC09</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-05</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7435/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC09</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286397" accession="ERS14397239">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397239</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286397</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286397</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251244</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC10</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-05</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7436/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC10</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286398" accession="ERS14397240">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397240</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286398</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286398</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251245</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC12</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-05</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7437/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC12</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286399" accession="ERS14397241">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397241</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286399</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286399</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251246</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC18</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-01</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7438/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC18</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286400" accession="ERS14397242">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397242</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286400</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286400</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251247</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC20</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-01</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7439/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC20</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286401" accession="ERS14397243">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397243</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286401</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286401</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251248</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC21</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-01</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7440/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Lysis</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC21</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286402" accession="ERS14397244">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397244</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286402</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286402</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251249</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC22</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-01</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7441/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC22</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286403" accession="ERS14397245">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397245</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286403</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286403</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251250</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC25</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-01</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7442/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC25</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286404" accession="ERS14397246">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397246</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286404</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286404</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251251</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-01</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7443/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC26</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286405" accession="ERS14397247">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397247</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286405</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286405</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251252</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7444/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC29</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286406" accession="ERS14397248">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397248</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286406</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286406</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251253</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC31</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7445/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC31</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286407" accession="ERS14397249">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397249</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286407</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286407</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251254</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC33</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7446/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC33</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286408" accession="ERS14397250">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397250</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286408</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286408</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251255</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC35</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7447/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC35</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286409" accession="ERS14397251">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397251</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286409</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286409</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251256</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC37</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7448/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC37</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286410" accession="ERS14397252">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397252</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286410</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286410</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251257</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC38</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7449/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC38</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286411" accession="ERS14397253">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397253</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286411</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286411</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251258</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC39</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7450/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC39</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286412" accession="ERS14397254">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397254</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286412</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286412</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251259</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC40</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7451/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC40</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286413" accession="ERS14397255">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397255</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286413</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286413</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251260</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC45</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-05</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7452/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC45</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286414" accession="ERS14397256">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397256</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286414</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286414</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251261</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC47</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-05</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7453/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC47</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286415" accession="ERS14397257">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397257</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286415</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286415</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251262</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC51</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-05</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7454/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC51</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286416" accession="ERS14397258">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397258</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286416</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286416</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251263</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC53</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-05</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7455/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC53</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286417" accession="ERS14397259">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397259</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286417</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286417</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251264</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC54</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-05</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7456/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC54</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286418" accession="ERS14397260">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397260</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286418</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286418</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251265</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC56</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7457/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC56</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286419" accession="ERS14397261">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397261</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286419</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286419</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251266</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC57</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7458/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC57</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286420" accession="ERS14397262">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397262</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286420</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286420</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251267</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC60</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7459/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC60</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286421" accession="ERS14397263">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397263</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286421</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286421</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251268</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC61</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7460/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC61</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286422" accession="ERS14397264">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397264</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286422</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286422</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251269</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC62</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7461/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC62</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286423" accession="ERS14397265">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397265</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286423</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286423</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251270</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC63</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7462/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC63</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286424" accession="ERS14397266">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397266</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286424</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286424</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251271</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC64</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7463/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC64</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286425" accession="ERS14397267">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397267</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286425</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286425</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251272</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC65</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7464/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC65</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286426" accession="ERS14397268">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397268</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286426</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286426</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251273</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC66</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7465/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC66</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286427" accession="ERS14397269">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397269</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286427</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286427</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251274</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC71</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-07</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7466/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC71</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286428" accession="ERS14397270">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397270</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286428</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286428</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251275</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC72</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-07</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7467/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC72</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286429" accession="ERS14397271">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397271</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286429</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286429</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251276</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC73</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-07</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7468/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC73</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286430" accession="ERS14397272">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397272</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286430</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286430</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251277</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC74</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-07</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7469/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC74</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286431" accession="ERS14397273">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397273</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286431</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286431</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251278</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC75</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-07</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7470/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC75</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286432" accession="ERS14397274">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397274</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286432</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286432</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251279</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC76</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-07</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7471/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC76</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286433" accession="ERS14397275">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397275</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286433</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286433</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251280</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC77</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7472/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC77</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286434" accession="ERS14397276">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397276</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286434</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286434</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251281</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC79</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-08</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7473/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC79</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286435" accession="ERS14397277">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397277</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286435</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286435</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251282</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC80</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-08</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7474/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC80</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286436" accession="ERS14397278">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397278</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286436</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286436</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251283</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:12Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC81</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-08</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7475/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC81</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286437" accession="ERS14397279">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397279</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286437</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286437</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251284</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC83</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-08</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7476/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC83</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286438" accession="ERS14397280">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397280</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286438</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286438</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251285</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC84</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-09</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7477/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC84</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286439" accession="ERS14397281">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397281</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286439</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286439</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251286</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC87</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-09</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7478/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC87</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286440" accession="ERS14397282">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397282</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286440</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286440</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251287</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC88</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-09</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7479/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC88</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286441" accession="ERS14397283">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397283</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286441</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286441</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251288</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC89</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-09</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7480/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC89</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286442" accession="ERS14397284">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397284</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286442</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286442</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251289</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC91</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-10</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7481/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC91</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286443" accession="ERS14397285">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397285</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286443</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286443</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251290</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC92</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-10</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7482/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC92</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286444" accession="ERS14397286">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397286</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286444</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286444</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251291</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC93</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-11</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7483/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC93</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286445" accession="ERS14397287">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397287</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286445</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286445</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16251292</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC94</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-11</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (region and locality)</TAG>
        <VALUE>Zuid-Holland</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/ZH-EMC-7484/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC94</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286446" accession="ERS14397288">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397288</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286446</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286446</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16260184</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC59</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-06</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/un-EMC-908/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC59</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="SAMEA112286447" accession="ERS14397289">
    <IDENTIFIERS>
      <PRIMARY_ID>ERS14397289</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMEA112286447</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Dutch COVID-19 response sample sequencing</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>2697049</TAXON_ID>
      <SCIENTIFIC_NAME>Severe acute respiratory syndrome coronavirus 2</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <DESCRIPTION>A SARS-CoV-2 specfic multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described. In short, primers for 86 overlapping amplicons spanning the entire genome were designed using primal. The amplicon length was set to 500bp with 75bp overlap between the different amplicons. The libraries were generated using the native barcode kits from Nanopore (EXP-NBD104 and EXP-NBD114 and SQK-LSK109) and sequenced on a R9.4 flow cell multiplexing up to 24 samples per sequence run. Raw data was demultiplexed, amplicon primers were trimmed and human data was removed by mapping against the human reference genome.</DESCRIPTION>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-01-04</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>External Id</TAG>
        <VALUE>SAMEA112286447</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>GISAID Accession ID</TAG>
        <VALUE>EPI_ISL_16260185</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center alias</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC center name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC first public</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC last update</TAG>
        <VALUE>2023-01-04T16:25:13Z</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>INSDC status</TAG>
        <VALUE>public</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>Submitter Id</TAG>
        <VALUE>Run793_BC69</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>broker name</TAG>
        <VALUE>Submission account for department of Viroscience's Research Teams, ErasmusMC</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collecting institution</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collection date</TAG>
        <VALUE>2022-12-07</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>collector name</TAG>
        <VALUE>Dutch COVID-19 response team</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>common name</TAG>
        <VALUE>Human coronavirus 2019</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>geographic location (country and/or sea)</TAG>
        <VALUE>Netherlands</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host common name</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host health state</TAG>
        <VALUE>not collected</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host scientific name</TAG>
        <VALUE>Homo sapiens</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host sex</TAG>
        <VALUE>not provided</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>host subject id</TAG>
        <VALUE>restricted access</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>hCoV-19/Netherlands/un-EMC-909/2022</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolation source host-associated</TAG>
        <VALUE>Throat/Nasal</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample capture status</TAG>
        <VALUE>active surveillance in response to outbreak</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sample name</TAG>
        <VALUE>Run793_BC69</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>scientific_name</TAG>
        <VALUE>Severe acute respiratory syndrome coronavirus 2</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
</SAMPLE_SET>
